We are live on ! Find out more
PGM

Parian Global Management Portfolio holdings

AUM $30.8M
1-Year Est. Return 51.25%
This Fund
S&P 500
This Quarter Est. Return
-33.3%
1 Year Est. Return
-51.25%
3 Year Est. Return
+65.19%
5 Year Est. Return
10 Year Est. Return
AUM
$48.5M
AUM Growth
-$76M
Cap. Flow
-$46.6M
Cap. Flow %
-96.06%
Top 10 Hldgs %
96.25%
Holding
34
New
1
Increased
3
Reduced
8
Closed
22

Top Buys

Rank Stock Value
1
SERA icon
Sera Prognostics
SERA
+$3.4M
2
CVRX icon
CVRx
CVRX
+$1.22M
3
STXS icon
Stereotaxis
STXS
+$584K
4
ADMA icon
ADMA Biologics
ADMA
+$491K

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$5.98M
2
QTRX icon
Quanterix
QTRX
+$2.76M
3
SGRY icon
Surgery Partners
SGRY
+$2.45M
4
USIO icon
Usio Inc
USIO
+$2.4M
5
ANGO icon
AngioDynamics
ANGO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USIO icon
26
Usio Inc
USIO
$61.3M
-551,013
Closed -$2.4M
XRAY icon
27
CALL
Dentsply Sirona
XRAY
$2.83B
-7,500
Closed -$418K
XRAY icon
28
Dentsply Sirona
XRAY
$2.83B
-37,578
Closed -$2.1M
RNLX
29
CALL
DELISTED
Renalytix plc American Depositary Shares
RNLX
-15,000
Closed -$239K
RNLX
30
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
-5,600
Closed -$89K
VAPO
31
CALL
DELISTED
Vapotherm, Inc. Common Stock
VAPO
-9,375
Closed -$1.55M
CELL
32
CALL
DELISTED
PhenomeX Inc. Common Stock
CELL
-120,000
Closed -$2.18M
ISO
33
DELISTED
IsoPlexis Corporation Common Stock
ISO
-122,330
Closed -$1.12M
LHDX
34
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-183,804
Closed -$1.58M

Similar funds

Parian Global Management's Q1 2022 Portfolio in Review

As of Q1 2022, Parian Global Management held 34 positions worth $48.5M, down 61% from $125M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Parian Global Management withdrew a net $46.6M in Q1 2022, closing 22 positions and reducing 8 holdings. Its most notable exit was Quanterix, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 87% a quarter earlier, followed by Technology.

Against the trend, Parian Global Management opened a new position in ADMA Biologics worth $576K.

  • Parian Global Management's largest Q1 2022 buy was ADMA Biologics: 315,000 shares worth $576K.
  • Parian Global Management added most to Sera Prognostics in Q1 2022, an estimated $3.4M increase.
  • Parian Global Management's biggest Q1 2022 reduction was iRhythm Holdings, cutting an estimated $5.98M.
  • Parian Global Management fully exited Quanterix in Q1 2022, selling an estimated $2.76M.
  • Parian Global Management's ten largest holdings make up 96% of its $48.5M portfolio in Q1 2022.
  • Parian Global Management opened 1 new position and closed 22 in Q1 2022.
  • Parian Global Management's portfolio value fell 61% quarter-over-quarter to $48.5M.

Based on Parian Global Management's 13F filing for Q1 2022, filed 16 May 2022.